Abbott ABT Established Pharmaceuticals — Goodwill, non-deductible
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
The total amount of goodwill reported was $35.2 billion at June 30, 2026, and $24.0 billion at December 31, 2025. Goodwill increased by $11.4 billion in the first six months of 2026 due to the completion of the Exact Sciences acquisition. Foreign currency translation adjustments decreased goodwill by $0.2 billion in the first six months of 2026. The amount of goodwill related to reportable segments at June 30, 2026, was $2.7 billion for the Established Pharmaceutical Products segment, $0.3 billion for the Nutritional Products segment, $15.0 billion for the Diagnostic Products segment, and $17.3 billion for the Medical Devices segment. The Diagnostic Products segment includes the amount of goodwill related to the Exact Sciences acquisition. There were no reductions of goodwill relating to impairments in the first six months of 2026.
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's established pharmaceuticals — goodwill, non-deductible?
- Abbott (ABT) reported established pharmaceuticals — goodwill, non-deductible of $2.7B in Q2 2026.
- How has Abbott's established pharmaceuticals — goodwill, non-deductible changed year-over-year?
- Abbott's established pharmaceuticals — goodwill, non-deductible decreased by 0.0% year-over-year, from $2.7B to $2.7B.
- What is the long-term trend for Abbott's established pharmaceuticals — goodwill, non-deductible?
- Over 4 years (2021 to 2025), Abbott's established pharmaceuticals — goodwill, non-deductible has grown at a -1.8% compound annual growth rate (CAGR), from $11.5B to $10.7B.
- What does established pharmaceuticals — goodwill, non-deductible mean?
- This metric represents the portion of goodwill associated with the Established Pharmaceuticals segment that is not tax-deductible. It reflects the premium paid over the fair value of net identifiable assets during acquisitions within this specific business unit, which cannot be amortized for tax purposes. This figure is a critical indicator of the long-term carrying value of intangible assets and potential impairment risks within the company's branded generic drug portfolio.
Ask your AI about Abbott's established pharmaceuticals — goodwill, non-deductible.
Connect your AI assistant and compare segments, right in your chat.
